Strong Tower Advisory Services Dexcom Inc Transaction History

Strong Tower Advisory Services

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$86.06 - $137.93 $9,380 - $15,034	109 Added 3.37%	3,345 $312,000
Q2 2023 Jul 13, 2023	BUY	$112.47 - $130.98 $8,547 - $9,954	76 Added 2.41%	3,236 $415,000
Q1 2023 Apr 14, 2023	SELL	$104.0 - $122.92 $13,728 - $16,225	-132 Reduced 4.01%	3,160 $367,000
Q4 2022 Jan 20, 2023	BUY	$84.98 - $122.67 $6,458 - $9,322	76 Added 2.36%	3,292 $0
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $164,807 - $322,125	2,424 Added 306.06%	3,216 $240,000
Q1 2022 Apr 14, 2022	SELL	$94.08 - $130.2 $846 - $1,171	-9 Reduced 1.12%	792 $405,000
Q4 2021 Jan 18, 2022	BUY	$129.87 - $162.82 $19,220 - $24,097	148 Added 22.66%	801 $430,000
Q3 2021 Oct 29, 2021	BUY	$106.71 - $143.18 $69,681 - $93,496	653 New	653 $358,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Strong Tower Advisory Services, based on Form 13F filings with the SEC.

Stay updated on Strong Tower Advisory Services with notifications on news.